Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma

doi:10.1007/s00280-017-3507-2

CORC > 昆明植物研究所 > 中国科学院昆明植物研究所 > 植物化学与西部植物资源持续利用国家重点实验室

	Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma
	Wang, Jingnan 1,2; Zhang, Zhirong1,2 ; Che, Yun 1,2; Yuan, Zuyang 1,2; Lu, Zhiliang 1,2; Li, Yuan 1,2; Wan, Jun 3; Sun, Handong3 ; Chen, Zhaoli 1,2; Pu, Jianxin3
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2018-03-01
卷号	81 期号:3 页码:469-481
关键词	Rabdocoestin b G2/m Phase Arrest Apoptosis Cytotoxicity Esophageal Squamous Cell Carcinoma
ISSN号	0344-5704
DOI	10.1007/s00280-017-3507-2
英文摘要	Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive squamous cell carcinomas and is generally resistant to chemotherapy. In the present study, the cytotoxic activity of Rabdocoestin B (Rabd-B) against ESCC and the underlying mechanisms were investigated.
语种	英语
WOS记录号	WOS:000426060100005
内容类型	期刊论文
源URL	[http://ir.kib.ac.cn/handle/151853/60543]
专题	昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
作者单位	1.Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Thorac Surg, Beijing 100021, Peoples R China 2.Peking Union Med Coll, Beijing 100021, Peoples R China 3.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
推荐引用方式 GB/T 7714	Wang, Jingnan,Zhang, Zhirong,Che, Yun,et al. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2018,81(3):469-481.
APA	Wang, Jingnan.,Zhang, Zhirong.,Che, Yun.,Yuan, Zuyang.,Lu, Zhiliang.,...&He, Jie.(2018).Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY,81(3),469-481.
MLA	Wang, Jingnan,et al."Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma".CANCER CHEMOTHERAPY AND PHARMACOLOGY 81.3(2018):469-481.